Skip to main content
OpenTrials

Clinical trial condition

Enterocolitis, Pseudomembranous

Explore clinical trials studying Enterocolitis, Pseudomembranous. Study availability and eligibility vary by location and protocol.

32 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Enterocolitis, Pseudomembranous trial results

Completed

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)

NCT03244644

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Clostridium Difficile Infection (CDI), +13 more
Locations
  • Athens Athens, Alabama, United States
  • Dothan Dothan, Alabama, United States
  • Phoenix Phoenix, Arizona, United States
  • North Little Rock North Little Rock, Arkansas, United States
View all 66 locations
View Trial Details
Completed

Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile Infection

NCT03806803

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Clostridia Difficile Colitis, +10 more
Locations
  • University of Alberta Hospital Edmonton, Alberta, Canada
  • University of British Columbia Vancouver, British Columbia, Canada
  • University of British Columbia Victoria, British Columbia, Canada
  • Mcgill University Health Centre Montreal, Quebec, Canada
View Trial Details
Completed

Safety and Efficacy of Multiple Daily Dosing of Oral LFF571 in Patients With Moderate Clostridium Difficile Infections

NCT01232595

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Clostridium Infections, +9 more
Locations
  • Novartis Investigative Site Palm Desert, California, United States
  • Novartis Investigative Site Bristol, Connecticut, United States
  • Novartis Investigative Site Clearwater, Florida, United States
  • Novartis Investigative Site Decatur, Georgia, United States
View all 18 locations
View Trial Details
Completed

Study of Different Formulations of a Clostridium Difficile Toxoid Vaccine Given at Three Different Schedules in Adults

NCT01230957

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Clostridium Difficile Infection, +13 more
Locations
  • Redding, California, United States
  • Bristol, Connecticut, United States
  • Stamford, Connecticut, United States
  • Clearwater, Florida, United States
View all 30 locations
View Trial Details

Related conditions